Structure (B19003ee Dd84 4104 Bcbc Ce752962aa59 01)
Acarbose Tablet
Product Images NDC 71335-9725
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Acarbose (NDC 71335-9725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (B19003ee Dd84 4104 Bcbc Ce752962aa59 02)
This is a chart showing the mean change in plasma glucose (in mg/dL) based on the dose of Acarbose tablets (taken three times a day) ranging from 25mg to 300mg. The data is broken down by the number of individuals in each group (N ranges from 53 to 244).*
Figure2 (B19003ee Dd84 4104 Bcbc Ce752962aa59 03)
The text appears to be a figure with four options labeled as B, C, and D that are possibly treatment options along with a chart that shows time in months on the x-axis and a value ranging from 3 to 6 on the y-axis. Other details are not available for further interpretation.*
Label (Lbl713359725)
This is a description of medicine named Acarbose Tablets, USP containing 50mg of acarbose. It is advised to keep this medicine and all medications away from children. Its container should be stored tightly closed and protected from moisture. This medicine package is child-resistant for safety. The tablets are manufactured by RA Chem Pharma Limited. There is also information on permitted excursions regarding temperature storage.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
